Asian Pacific Journal of Cancer Prevention

  • 제13권5호
  • /
  • Pages.2329-2334
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Role of MicroRNA-21 in Non-small Cell Lung Cancer: a Meta-analysis

  • Ma, Xue-Lei (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Liu, Lei (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Liu, Xiao-Xiao (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Li, Yun (Department of Respiratory Medicine,West China Hospital, Sichuan University) ;
  • Deng, Lei (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Xiao, Zhi-Lan (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Liu, Yan-Tong (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Shi, Hua-Shan (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University) ;
  • Wei, Yu-Quan (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University)
  • 발행 : 2012.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Introduction: Many studies have reported that microRNA-21 (miR-21) mihght predict the survival outcome in non-small cell lung cancers (NSCLCs) but the opposite opinion has also been expressed. The aim of this study was to summarize the evidence for a prognostic role of miR-21. Materials and Methods: All the eligible studies was searched by Medline and EMBASE and patients' clinical characteristics and survival outcome were extracted. Then a meta-analysis was performed to clarify the prognostic role of the miR-21 expression in different subgroups. Results: A total of 8 eligible articles were yielded covering survival outcomes or clinical characteristics. The combined hazard ratio (HR) and 95% confidence interval (95% CI) for overall survival (OS) was 2.19 [0.76, 6.30], while the combined HR (95% CI) of Asian group for OS had a significant result, 5.49 [2.46, 12.27]. The combined HR (95% CI) for recurrence free survival or disease free survival (RFS/DFS) was 2.31 [1.52, 3.49]. Odds ratios (ORs) showed that the miR-21 expression was associated with lymph node status and histological type. Conclusion: miR-21 expression could predict the prognostic outcome of NSCLC in Asians, despite some deficiencies in the study data.

키워드

참고문헌

  1. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
  2. Bartel DP, Chen CZ (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet, 5, 396-400.
  3. Begg CB (1994). Publication bias. 299(409): 25.
  4. Cornfield J (1951). A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst, 11, 1269-75.
  5. de Planell-Saguer M, Rodicio MC (2011). Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta, 699, 134-52. https://doi.org/10.1016/j.aca.2011.05.025
  6. Diederichs S, Haber DA (2006). Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res, 66, 6097-104. https://doi.org/10.1158/0008-5472.CAN-06-0537
  7. Gao W, Lu X, Liu L, et al (2012). MiRNA-21: A biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer. Cancer Biol Ther, 13, 330-40. https://doi.org/10.4161/cbt.19073
  8. Gao W, Shen H, Liu L, et al (2011). MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol, 137, 557-66. https://doi.org/10.1007/s00432-010-0918-4
  9. Gao W, Xu J, Liu L, et al (2012). A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother, 66, 21-8. https://doi.org/10.1016/j.biopha.2011.09.004
  10. Gao W, Yu Y, Cao H, et al (2010). Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother, 64, 399-408. https://doi.org/10.1016/j.biopha.2010.01.018
  11. Hatley ME, Patrick DM, Garcia MR, et al (2010). Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell, 18, 282-93. https://doi.org/10.1016/j.ccr.2010.08.013
  12. Hayes DF, Isaacs C, Stearns V (2001). Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia, 6, 375-92. https://doi.org/10.1023/A:1014778713034
  13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
  14. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  15. Lawrie CH, Soneji S, Marafioti T, et al (2007). MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer, 121, 1156-61. https://doi.org/10.1002/ijc.22800
  16. Liang Y (2008). An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics, 1, 61. https://doi.org/10.1186/1755-8794-1-61
  17. Liu XG, Zhu WY, Huang YY, et al (2011). High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol, 29, 618-26.
  18. Lu Z, Liu M, Stribinskis V, et al (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 27, 4373-9. https://doi.org/10.1038/onc.2008.72
  19. Markou A, Tsaroucha EG, Kaklamanis L, et al (2008). Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem, 54, 1696-704. https://doi.org/10.1373/clinchem.2007.101741
  20. Nielsen BS, Jorgensen S, Fog JU, et al (2011). High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis, 28, 27-38. https://doi.org/10.1007/s10585-010-9355-7
  21. Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
  22. Qian B, Katsaros D, Lu L, et al (2009). High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat, 117, 131-40. https://doi.org/10.1007/s10549-008-0219-7
  23. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP (1998). Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database. J Clin Oncol, 16, 651-7. https://doi.org/10.1200/JCO.1998.16.2.651
  24. Saito M, Schetter AJ, Mollerup S, et al (2011). The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res, 17, 1875-82. https://doi.org/10.1158/1078-0432.CCR-10-2961
  25. Siva AC, Nelson LJ, Fleischer CL, et al (2009). Molecular assays for the detection of microRNAs in prostate cancer. Mol Cancer, 8, 17.
  26. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 16. https://doi.org/10.1186/1745-6215-8-16
  27. Voortman J, Goto A, Mendiboure J, et al (2010). MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res, 70, 8288-98. https://doi.org/10.1158/0008-5472.CAN-10-1348
  28. Wang QZ, Xu W, Habib N, Xu R (2009). Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets, 9, 572-94. https://doi.org/10.2174/156800909788486731
  29. Wang ZX, Bian HB, Wang JR, et al (2011). Prognostic significance of serum miRNA-21 expression in human nonsmall cell lung cancer. J Surg Oncol, 104, 847-51. https://doi.org/10.1002/jso.22008
  30. Wei J, Gao W, Zhu CJ, et al (2011). Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer, 30, 407-14. https://doi.org/10.5732/cjc.010.10522
  31. Williamson PR, Smith CT, Hutton JL, Marson AG (2002). Aggregate data meta-analysis with time-to-event outcomes. Stat Med, 21, 3337-51. https://doi.org/10.1002/sim.1303
  32. Yang CH, Yue J, Pfeffer SR, Handorf CR, Pfeffer LM (2011). MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem, 286, 39172-8. https://doi.org/10.1074/jbc.M111.285098
  33. Zhang JG, Wang JJ, Zhao F, et al (2010). MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta, 411, 846-52. https://doi.org/10.1016/j.cca.2010.02.074

피인용 문헌

  1. Prognostic Role of microRNA-21 in Colorectal Cancer: a Meta-Analysis vol.8, pp.11, 2013, https://doi.org/10.1371/journal.pone.0080426
  2. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer vol.31, pp.10, 2014, https://doi.org/10.1007/s12032-014-0235-x
  3. Prediction of Poor Prognosis in Breast Cancer Patients Based on MicroRNA-21 Expression: A Meta-Analysis vol.10, pp.2, 2015, https://doi.org/10.1371/journal.pone.0118647
  4. Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0121547
  5. Discovering MicroRNA-Regulatory Modules in Multi-Dimensional Cancer Genomic Data: A Survey of Computational Methods vol.15s2, pp.1176-9351, 2016, https://doi.org/10.4137/CIN.S39369
  6. Emerging role of microRNA-21 in cancer vol.5, pp.4, 2016, https://doi.org/10.3892/br.2016.747
  7. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis vol.2018, pp.1875-8630, 2018, https://doi.org/10.1155/2018/8309015